Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Change Your Home into an Exercise center with These Famous Wellness Gadgets - 2Surprising links between autism, Alzheimer’s could change how we treat both
- 3The beauty advent calendar boom is here. Sephora kids are all in.
- 4Eight Muslim nations condemn Israel's 'dangerous' new death penalty law
- 5Flourishing as a Charitable Pioneer: Individual Encounters in Generosity
- Vote In favor of Your Favored Web-based Book Retailor
- Turning into a Distributed Writer: My Composing Process
- Doctor's orders? ‘Belly laugh at least two to five days a week'
- Dozens injured in Russia after train crashes, overturns
- How the Iran war may affect your money and bills
- 6 Web-based Staple Help You Can Trust
- The 10 Most Persuasive Forerunners in Innovation
- Why most Jewish Israelis back the death penalty for terrorists
- IDF drops over 80 explosives on Tehran weapon production sites in latest strike
